These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient-derived orthotopic xenograft (PDOX) model. Kawaguchi K; Igarashi K; Murakami T; Chmielowski B; Kiyuna T; Zhao M; Zhang Y; Singh A; Unno M; Nelson SD; Russell TA; Dry SM; Li Y; Eilber FC; Hoffman RM Oncotarget; 2016 Dec; 7(52):85929-85936. PubMed ID: 27835903 [TBL] [Abstract][Full Text] [Related]
7. Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models. Kawaguchi K; Miyake K; Zhao M; Kiyuna T; Igarashi K; Miyake M; Higuchi T; Oshiro H; Bouvet M; Unno M; Hoffman RM Cell Cycle; 2018; 17(16):2019-2026. PubMed ID: 29963961 [TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) model. Murakami T; DeLong J; Eilber FC; Zhao M; Zhang Y; Zhang N; Singh A; Russell T; Deng S; Reynoso J; Quan C; Hiroshima Y; Matsuyama R; Chishima T; Tanaka K; Bouvet M; Chawla S; Endo I; Hoffman RM Oncotarget; 2016 Mar; 7(11):12783-90. PubMed ID: 26859573 [TBL] [Abstract][Full Text] [Related]
9. Combining Tumor-Selective Bacterial Therapy with Salmonella typhimurium A1-R and Cancer Metabolism Targeting with Oral Recombinant Methioninase Regressed an Ewing's Sarcoma in a Patient-Derived Orthotopic Xenograft Model. Miyake K; Kiyuna T; Li S; Han Q; Tan Y; Zhao M; Oshiro H; Kawaguchi K; Higuchi T; Zhang Z; Razmjooei S; Barangi M; Wangsiricharoen S; Murakami T; Singh AS; Li Y; Nelson SD; Eilber FC; Bouvet M; Hiroshima Y; Chishima T; Matsuyama R; Singh SR; Endo I; Hoffman RM Chemotherapy; 2018; 63(5):278-283. PubMed ID: 30673664 [TBL] [Abstract][Full Text] [Related]
10. Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Zhao M; Geller J; Ma H; Yang M; Penman S; Hoffman RM Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10170-4. PubMed ID: 17548809 [TBL] [Abstract][Full Text] [Related]
11. High-efficacy targeting of colon-cancer liver metastasis with Salmonella typhimurium A1-R via intra-portal-vein injection in orthotopic nude-mouse models. Kawaguchi K; Murakami T; Suetsugu A; Kiyuna T; Igarashi K; Hiroshima Y; Zhao M; Zhang Y; Bouvet M; Clary BM; Unno M; Hoffman RM Oncotarget; 2017 Mar; 8(12):19065-19073. PubMed ID: 27683127 [TBL] [Abstract][Full Text] [Related]
12. Salmonella typhimurium A1-R targeting of a chemotherapy-resistant BRAF-V600E melanoma in a patient-derived orthotopic xenograft (PDOX) model is enhanced in combination with either vemurafenib or temozolomide. Kawaguchi K; Igarashi K; Murakami T; Kiyuna T; Zhao M; Zhang Y; Nelson SD; Russell TA; Dry SM; Singh AS; Chmielowski B; Li Y; Unno M; Eilber FC; Hoffman RM Cell Cycle; 2017 Jul; 16(13):1288-1294. PubMed ID: 28622068 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models. Hiroshima Y; Zhang Y; Murakami T; Maawy A; Miwa S; Yamamoto M; Yano S; Sato S; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Endo I; Zhao M; Hoffman RM Oncotarget; 2014 Dec; 5(23):12346-57. PubMed ID: 25402324 [TBL] [Abstract][Full Text] [Related]
14. Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models. Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Miyake M; Singh AS; Eckardt MA; Nelson SD; Russell TA; Dry SM; Li Y; Yamamoto N; Hayashi K; Kimura H; Miwa S; Tsuchiya H; Singh SR; Eilber FC; Hoffman RM Biochem Biophys Res Commun; 2018 Mar; 497(4):1055-1061. PubMed ID: 29481803 [TBL] [Abstract][Full Text] [Related]